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Abstract
Trauma and sepsis can cause acute lung injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) in part by triggering
neutrophil (PMN)-mediated increases in endothelial cell (EC) permeability. We had shown that mitochondrial (mt) damage-
associated molecular patterns (DAMPs) appear in the blood after injury or shock and activate human PMN. So we now
hypothesized that mitochondrial DAMPs (MTD) like mitochondrial DNA (mtDNA) and peptides might play a role in increased
EC permeability during systemic inflammation and proceeded to evaluate the underlying mechanisms. MtDNA induced
changes in EC permeability occurred in two phases: a brief, PMN-independent ‘spike’ in permeability was followed by
a prolonged PMN-dependent increase in permeability. Fragmented mitochondria (MTD) caused PMN-independent increase
in EC permeability that were abolished with protease treatment. Exposure to mtDNA caused PMN-EC adherence by
activating expression of adherence molecule expression in both cell types. Cellular activation was manifested as an increase
in PMN calcium flux and EC MAPK phosphorylation. Permeability and PMN adherence were attenuated by endosomal TLR
inhibitors. EC lacked formyl peptide receptors but were nonetheless activated by mt-proteins, showing that non-formylated
mt-protein DAMPs can activate EC. Mitochondrial DAMPs can be released into the circulation by many processes that cause
cell injury and lead to pathologic endothelial permeability. We show here that mitochondria contain multiple DAMP motifs
that can act on EC and/or PMN via multiple pathways. This can enhance PMN adherence to EC, activate PMN-EC interactions
and subsequently increase systemic endothelial permeability. Mitochondrial DAMPs may be important therapeutic targets
in conditions where inflammation pathologically increases endothelial permeability.
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Introduction
Cellular damage due to mechanical trauma, hemorrhage and
sepsis can release mitochondrial (mt) damage motifs like
mtDNA and formyl peptides. We previously showed that these
molecules can trigger inflammation and organ injury (in vivo)b y
activating PMN [1,2]. Thus mtDNA and formyl peptides clearly
act as systemic alarmins or damage-associated molecular
patterns (DAMPs) [3,4] The mechanisms by which mt-DAMPs
(MTD) act on other cells however, and the molecular events by
which MTD induce the systemic inflammatory response
syndrome (SIRS) and organ dysfunction are poorly understood.
It is known though, that a major mechanism by which innate
immunity causes organ dysfunction is instigation of PMN-
mediated increases in endothelial cell (EC) permeability. Here
for the first time we test the hypothesis that human
mitochondrial ‘damage’ motifs (like mtDNA and mt-proteins)
released following cell injury in vivo can trigger endothelial
permeability changes observed in acute lung injury and acute
respiratory distress syndrome (ARDS) (ALI/ARDS). We also set
out to determine whether these effects occur via MTD
interactions with EC, PMN or both. To study these processes
under the most realistic and relevant possible conditions, we
created studies that centered on the changes in endothelial
monolayer permeability occurring ‘in real-time’ when human
EC were exposed to fragmented whole human mitochondria
(MTD) or to purified mtDNA in the presence or absence of
human PMN. We then focused on the molecular biologic and
cell signaling events that led to the alterations in EC
permeability seen in the translational models we had created.
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Compliance
The study was approved by the Institutional Review Board
(IRB) of Beth Israel Deaconess Medical Center, Boston, MA USA.
Written consent was obtained from blood donors. The tissue
samples obtained for isolation of human mitochondria were
portions of surgical pathology specimens that were not needed for
diagnostic purposes. All samples were de-identified.
Preparation of MTD and mtDNA
Human tissues such as the margins of liver resections, portions
of spleens removed due to injury and bone marrow reamed from
the femur during fracture fixations were obtained from operations
performed at Beth Israel Deaconess Medical Center (BIDMC).
Whole mitochondria (mt) were prepared using a mitochondrial
isolation kit from Thermo Fisher Scientific (Rockford, IL). For
certain experiments, mitochondrial debris (MTD) fractions were
prepared by sonicating whole mitochondria (prepared from
human liver) five times for 30 s as previously described [2]. Thus
MTD contains both mitochondrial proteins and mitochondrial
DNA.
Activity of MTD samples was standardized using a bio-assay
based upon the ability of MTD to elicit a [Ca
2+]i response in Fura
2-loaded human PMN equal to that induced by 1 nM fMLP [5].
This method allowed us to use mitochondria from different tissue
sources with minimal variation in activity. Concentrations are
therefore expressed as dilution factors from the initial mitochon-
drial suspension. Preparations from different individuals still varied
slightly in their ability to increase endothelial permeability and
application, even at the same concentration based on PCR cycles
or on PMN Ca
2+ response, does not guarantee identical changes in
permeability. This approach is by necessity very different from
using commercial agents that are purified and fully characterized,
but also reflects real biologic variability.
Protease treated whole mitochondria (MT) or MTD were
prepared by treating samples with QIAGEN Protease (Qiagen) [6]
at 56uC for 20 min. The protease was then inactivated by heating
at 75uC for 20 min. Mitochondrial DNA (mtDNA) was prepared
from human liver samples using the mtDNA Extractor (R) CT Kit
from WAKO Chemical (Richmond, VA). Activity and purity of
the mtDNA was evaluated by quantitative PCR using mitochon-
dria specific primers [2]. MTD and mtDNA samples were
evaluated and contained no detectable endotoxin.
Endothelial Cell Cultures and Chemicals
EA.hy926 cells [7], derived from the fusion of HUVECs with
the human lung carcinoma cell line A549, were obtained from Dr.
Cora-Jean C. Edgell (University of North Carolina at Chapel Hill,
NC). These ‘‘EA’’ cells were maintained in DMEM medium with
10% FBS and penicillin and streptomycin in a CO2 (5%)
incubator at 37uC [8]. We chose to use EA cells for the bulk of
the studies described in this manuscript since they maintain stable
morphological, phenotypic and functional characteristics similar to
human macro-vascular endothelial cells. Primary endothelial cells
from different donors have limited life spans and different
characteristics from batch to batch. To generalize studies done
in EA cells critical findings were confirmed by using human
pulmonary artery endothelial cells (HPAEC) or human lung
microvascular endothelial cells (HMVEC). HPAEC and HMVEC
were purchased from Lonza (Walkersville, MD) and maintained in
EGM-2 and EGM-2MV medium, respectively. Chloroquine (an
inhibitor of endosomal acidification) and ODN TTAGGG (an
inhibitor of mtDNA binding to TLR9) were purchased from
Invivogen (Carlsbad, CA). Other chemicals were purchased from
Sigma (St. Louis, MI).
Human PMN Preparations
PMN were isolated fresh from healthy volunteer donor blood
samples. Detailed methods for PMN preparation can be found
elsewhere [9]. Briefly, PMN were isolated from heparinized whole
blood using a one-step centrifugation procedure in ‘‘PMN’’
isolation medium (Thermo Fisher Scientific). The neutrophil layer
was collected, osmolarity was restored and cells were then washed
and suspended in HEPES buffer. Red blood cells were lysed
briefly to increase PMN purity.
EC Permeability Measurements
Transendothelial electrical resistance (TER) was measured by
seeding endothelial cells onto Cysteine/fibronectin-pretreated 8-
well gold microelectrode chambers (8W10E+, 40 micro-electrodes
per well) connected to an ECIS system (Applied BioPhysics). This
system measures changes in the impedance of microelectrodes
underlying the monolayer when an alternating current (AC) is
applied. The tiny AC current (,1 mA) and voltage changes across
the cells (a few millivolts) that are used to make the measurements
have no detectable effect on the cells [8,10,11]. Confluence is
determined by impedance coming to a plateau after overnight
incubation (37uC, 5% CO2) as per the manufacturer’s protocol.
These measurements provide a highly sensitive real-time bio-
physical assay indicating the state of cell shape and focal adhesion.
As recommended by the manufacture, we assess capacitance
changes at 64,000 Hz to evaluate monolayer permeability. As
previously published, we normalize capacitance values for each
well, dividing the observed value by the capacitance at plateau just
prior to treatment [8,11]. Values from each microelectrode are
then pooled at discrete time points and plotted versus time as the
mean 6 SD. As permeability increases, impedance and resistance
decrease whereas capacitance increases.
Western Blot Analysis
Whole cell lysates were prepared using RIPA buffer (Thermo
Fisher Scientific, Rockford, IL) following the manufacturer’s
protocol. Primary antibodies against phospho-p38 (Thr180/
Tyr182), phospho-p44/42 MAPK (Erk1/2), p38 MAPK, p44/
42 MAPK (Erk1/2) antibodies were purchased from Cell
Signaling Technology (Beverly, MA). HMGB1 antibody was
purchased from abcam (Cambridge, MA). We used either b-actin
(Santa Cruz Biotechnology, Santa Cruz, CA) or a-tubulin (Sigma,
St. Louis, MI) as a house keeping protein. ECL (Thermo Fisher
Scientific) was used to visualize proteins recognized by antibodies.
Detailed procedures can be found elsewhere [9].
RNA and cDNA Preparation and Quantitative PCR
RNA and cDNA were prepared using the RNesay mini kit
(Qiagen, Valencia, CA) and the SuperScript VILO cDNA
Synthesis kit (Life Technologies, Carlsbad, CA), respectively.
100–200 ng of cDNA was applied per qPCR reaction. Expression
levels for E-selectin, ICAM-1, CD11b, CD18, L-selectin,
HMGB1, and TLR9 were all determined by qPCR using
SYBR-Green technology and STEP-ONE-Plus (Life Technolo-
gies, Carlsbad, CA) with specific primers purchased from OriGene
(Rockville, MD). The expression levels for Sphingosine kinase 1
(Sphk1) were determined by TaqMan qPCR using validated
specific primers and probe (Life Technologies, Carlsbad, CA).
200 ng of cDNA was loaded per reaction. All data were further
normalized using GAPDH as the housekeeping gene. The levels of
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conditions used in these studies, further demonstrating the internal
stability of this housekeeping control under the experimental
conditions used.
Human PMN-Endothelial Cell Adhesion Assay
PMN were incubated for 30 minutes at 37uC in the dark in
HEPES buffer with 1 mM Ca
2+ and 3 mM Calcein-AM. Calcein-
loaded PMN were set aside for use as a standard curve. PMN-EC
adhesion assays were performed as previously described [8]. Near-
confluent EC monolayers were stimulated with mtDNA (10–
20 mg/mL) or medium for 6 hours. Labeled PMN (2.5610
5) were
added for 1 hour after which the plates were inverted and
centrifuged at 2006g for 5 min to remove non-adherent PMN.
The calcein fluorescence of remaining PMN was then measured
using a fluorescent plate reader (SpectaMax: Molecular Devices,
Sunnyvale, CA) set at an excitation wavelength of 485 nm and an
emission wavelength of 520 nm.
Intracellular Calcium Measurements by Calcium Imaging
EC calcium mobilization was determined using a fluorescent
calcium imaging system where cells are attached to glass
coverslips. Cells were loaded with Fura-2 [8] and the intracellular
calcium concentration ([Ca
2+]i) was monitored with a Basic InCyt
Im2 calcium imaging system (Intracellular Imaging Inc., Cincin-
nati, Ohio). 20–30 cells were typically selected for each
experiment. The ratio of fluorescence at 340/380 nm was used
to indicate [Ca
2+]i.
Imaging of mtDNA Localization in HPAEC by Confocal
Microscopy
To visualize localization of mtDNA in HPAEC, human mtDNA
was labeled with Alexa 488 using the Ulysis Nucleic Acid Labeling
Kit (Life technologies, Grand Island, NY) following the manu-
facturer’s protocol [12]. Free Alexa 488 was removed by Micro
Bio-Spin P-30 (Bio-Rad, Hercules, CA). HPAEC were stimulated
with Alexa 488 labeled mtDNA and the red vital dye FM4-64 (Life
Technologies) to visualize endocytosis. Cells were incubated for
4 hrs and a brief treatment with NucBlue (Life technologies) was
used to label nuclei. Medium was then replaced with Live Cell
Imaging Solution (Life technologies). Live cells were imaged at
37uC with 5%CO2 using a Zeiss LSM 510 Meta Live Cell
Inverted Confocal System.
Results
MTD Directly Increase Endothelial Permeability
MTD applied to EA cells showed marked effects in endothelial
permeability in the absence of PMN. As shown in Figure 1A,
MTD dose-dependently increased endothelial permeability. To
confirm the effects of MTD on primary human endothelial cells
and show that its effect on permeability was not limited to one
specific cell type, we applied MTD (61/25) to human pulmonary
artery endothelial cells (HPAEC). The changes seen were less than
EA cells, but MTD still induced significant permeability increases
(Figure 1B). Protease-treated MTD had no effect on permeabil-
ity. Control conditions using heat-inactivated protease, medium
and HBSS showed no effects on permeability. The addition of
human PMN to EC monolayers already treated with MTD yields
no additional effect on permeability (Figure 1C) and unstimu-
lated alone PMN had no measurable effect on EC monolayer
permeability (Figure 1D).
MtDNA Increases EC Permeability both Directly and
Indirectly via PMN
MtDNA (25 and 50 mg/mL) was prepared from mitochondria
isolated from human liver and applied to EA cells with and
without human PMN present. We note an immediate, dose-
dependent rise in monolayer permeability both in the presence
and absence of PMN (Figure 2A). In the absence of PMN
however, permeability changes were transient and decayed
relatively quickly. In the presence of PMN the increases in
permeability were sustained and even intensified over time. We
repeated this study in the presence of the oligodeoxynuclotide
(ODN) TTAGGG, which is a selective inhibitor of endosomal
nucleic acid receptors. [13] TTAGGG markedly attenuated the
induction of permeability by mtDNA in the presence of human
PMN (Figure 2B).
Chloroquine Inhibits MTD-induced Permeability Changes
Hypomethylated DNA species like mtDNA are thought to be
sensed through endosomal DNA receptors such as TLR 3, 7, 8
and 9 that require endosomal acidification. Since MT contain
hypomethylated CpG DNA we examined the effects of chloro-
quine (CQ, an inhibitor of endosomal acidification [14]) on MTD-
induced EC permeability in the absence of PMN. Endothelial cells
pre-treated with CQ showed significant attenuation of MTD-
induced permeability. This suggests that EC sensing of mtDNA via
endosomal nucleic acid receptors contributes to the permeability
increase caused by MT (Figure 2C).
MtDNA Had Limited Effects on HMVEC
The effects of mtDNA or CpG with or without PMN on
permeability of human pulmonary microvascular endothelial cells
(HMVEC) with or without PMN were also evaluated. As seen in
Figure 2D, the responses of microvascular EC to both endosomal
and cell membrane TLR agonists were found to be limited and
slow in these systems compared with the responses of EA cells or
pulmonary artery EC.
MtDNA is Taken Up into Endosomes by HPAEC
DNA-sensing TLRs are endosomal in location. We therefore
next sought to show that mtDNA applied to EC externally was
taken up into endosomes. To do this, we applied mtDNA prepared
from human liver and freshly labeled with Alexa 488 to HPAEC
along with FM4-64, a marker that localizes to endosomes. We
then examined live cells under confocal microscopy. As shown in
Figure 3, mtDNA was noted to be taken up rapidly by HPAEC
and to co-localize to the endosomes as determined using FM4-64.
Mitochondrial Proteins Induce EC Permeability and Ca
2+
Mobilization Directly
In addition to mtDNA, mitochondria contain proteins that EC
might sense as alarmins. These could be formylated proteins
synthesized in the mitochondria that act on formyl peptide
receptors (FPR) like those on PMN, or they could be non-
formylated proteins sensed via other mechanisms. We examined
the permeability of EC exposed to MTD pre-treated with
a protease cocktail or media only [6]. Protease activity was
terminated by heat (75uC/20 min) prior to treating EC. As shown
in Figure 4A, protease treatment of MTD markedly reduced their
ability to induce an increase in EC permeability, although that
reduction was incomplete. Heat treatment alone had no effect on
the activity of MT. Also, heat-treated proteases (HBSS+protease)
have no effect on EC permeability even though direct treatment of
Mitochondrial DAMPs and Endothelial Permeability
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dramatically increases permeability (Figure 4B).
Agonists like thrombin and histamine increase EC permeability
in part by increasing cytosolic calcium concentrations ([Ca
2+]i).
We therefore applied MTD to EA cells or HPAEC to evaluate
calcium mobilization (Figure 4C and D). Experiments per-
formed in the absence of extracellular calcium showed that MTD
(61/25, applied at t=60 sec) induced release of intracellular
calcium stores in both EA cells and HPAEC. Addition of
extracellular calcium (1.8 mM, applied 600–700 sec after MTD)
showed that MTD also causes a Ca
2+ influx. This was more
prominent in the EA cells. Lastly, when MTD were pre-treated
with a protease cocktail (P-MTD) the [Ca
2+]i increases were very
limited.
Formyl Peptides Do Not Induce EC Permeability Directly
We next examined whether mitochondrial formyl peptides
contribute directly or in an additive manner to the permeability of
EC exposed to MTD or mtDNA. We found that fMLP (10 nM)
had no direct effect on EC permeability. Moreover, application of
fMLP to EC in addition to MTD or mtDNA had no additional
effect on the permeability changes seen (Figure 5A). EA cells
studied by fluorescence microscopy showed no [Ca
2+]i transients
in response to fMLP despite responding briskly to thrombin
stimulation. This suggests the absence of formyl peptide receptors
(FPRs) (Figure 5B). Taken together, these data suggest that non-
formylated MT proteins (of genomic origin) cause changes in EC
permeability directly, and that exposure to non-formylated MT-
Figure 1. MTD-induced Permeability changes in EA and HPAEC. (A) EA cells were seeded onto ECIS cultureware (8W10E+). Various
concentrations (61/100, 61/50, 61/25) of MTD were applied to EA cells at time ‘‘0’’ and capacitance changes were determined as described
previously [8]. (B) HPAEC were applied to ECIS cultureware as describe in 1A. The magnitude of responses is different from EA cells but MTD (61/25)
markedly increases permeability in HPAEC as well. Protease-treated MTD does not increase permeability. Proteases were always heat inactivated
before application of MTD to HPAEC. MTD activity is unaffected by heat. Heat-treated protease itself (HBSS-protease), medium and HBSS have no
effect on EC permeability. (C) MTD (61/25), PMN (2610
5/well) from healthy volunteers were applied to EA cells along with MTD or in medium alone
(N=3 for MTD and MTD+PMN, N=2 for Medium). (D) EA cells treated with medium or unstimulated PMN. These are control condition that apply to all
ECIS experiments with EA cells. To avoid repetition, we show the typical medium or PMN (2610
5 cells/well) treated EA cell responses. For 1A, B, C:
Values were collected every 160 sec at 64,000 Hz as recommended by manufacture. Data were collected from 2–3 wells and each well has 40
electrodes. Thus each data point represents mean and SD values from at least total of 80 electrodes. All experiments were repeated at least three
times.
doi:10.1371/journal.pone.0059989.g001
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permeability after injury.
MtDNA Activates PMN Adherence to EC
Next, we examined whether enhanced PMN-EC adherence
might contribute to the increased permeability observed when
PMN and EC were exposed to mitochondrial alarmins. EA cells
were treated with mtDNA (10, 20 mg/mL) for 6 hrs and calcein-
loaded PMN were applied to the EA cell monolayers for the last
60 min. Exposure to mtDNA significantly increased PMN
adherence to EA cells (Figure 6A). We therefore treated EA cells
with mtDNA and evaluated their expression of ICAM-1 and E-
selectin by qPCR. We found expression of these adhesion
molecules to be dramatically increased (Figure 6B). We also
examined whether mtDNA increased PMN expression of the
relevant counter-ligands and found that it markedly increased
PMN expression of CD18b and L-selectin (Figure 6 C&D). Thus
exposure to mtDNA increases expression of selectins and integrins
in both PMN and EC and causes them to adhere to each other.
MtDNA Activates PMN Store Operated Calcium Entry
(SOCE)
We previously showed that PMN are activated via increases in
SOCE after clinical injury [15] although the mechanisms of that
SOCE activation were unknown at the time. We now hypothe-
sized that exposure to mitochondrial DAMPs might contribute to
the increased PMN SOCE we found after clinical injury. We
found that exposure to mtDNA did indeed increase thapsigargin
(TG) induced PMN calcium influx significantly (Figure 7A). We
have also previously shown [16] that enhanced SOCE in PMN
was related to the increased generation of sphingosine 1-phosphate
(S1P). Sphingosine kinase-1 (Sphk1) is the major bio-synthetic
pathway for S1P synthesis. We therefore questioned whether
exposure to mtDNA might increase PMN expression of Sphk1,
thus increasing intracellular production of S1P and leading to
increased [Ca
2+]i. We observed (Figure 7B) that mtDNA
treatment did indeed enhance PMN expression of Sphk1 mRNA.
The data support a general hypothesis that release of mitochon-
drial DAMPs by injury can activate PMN-EC interactions by
increasing PMN SOCE and thus activating [Ca
2+]i dependent
PMN inflammatory responses.
Figure 2. mtDNA and MTD induce permeability in EA calls. (A) mtDNA-induced endothelial permeability changes were evaluated by ECIS as
described in Figure 1. EA cells were seeded onto ECIS cultureware and 25 or 50 mg/mL mtDNA was applied with or without 2–3610
5 human PMN. (B)
In addition to the conditions in 2A, 5 mM ODN TTAGGG (a specific inhibitor of TLR9) was applied to chambers where indicated. Two or three wells
were used per reaction, mean and SD values are shown. (C) EA cells were pre-treated with 10 or 50 mM Chloroquine then MTD (61/25) were applied.
Two or three wells are used per reaction, mean and SD values are shown. For 2A, B and C the conditions were the same as described in Figure 1. All
experiments were repeated at least three times. (D) Unlike EA or HPAEC, HMVEC have very slow and limited responses to stimulation.
doi:10.1371/journal.pone.0059989.g002
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Induction of ICAM-1 in endothelial cells is known to be under
the control of MAP kinases [17] and we observed here that
mtDNA induces ICAM-1 expression (Figure 6B). Also, we
previously showed that mtDNA only activates p38-MAPK but not
p44/42 MAPK (Erk1/2) in PMN whereas MTD activates both
kinases [2]. We therefore investigated whether mitochondrial
DAMPs could activate endothelial cell MAPKs. EA cells were
treated with MTD (61/40 dilution) for various time periods.
Whole cell lysates were then prepared for Western Blot analysis.
As seen in Figure 8A, MTD caused a rapid phosphorylation of
p38-MAPK in EA cells. MTD treatment also resulted in
phosphorylation of p44/42 MAPK, although with noticeably
different kinetics compared to p38 (Figure 8B). These findings
are consistent with the conclusion that mitochondrial DAMPs
activate endothelial cell MAPK by more than one pathway, much
as seen in PMN.
MTD Up-regulates Endothelial Expression of HMGB1
HMGB1 is a non-histone nuclear protein that can be released
directly in response to tissue injury [18] or as a cytokine late in
inflammation. HMGB1 is known to activate innate immunity via
TLR2, TLR4 and the RAGE receptor [19]. EC exposure to
HMGB1 has also been suggested as an important regulator of
vascular permeability [20]. We therefore studied whether exposure
to MT might result in autocrine or paracrine activation of EC
permeability via HMGB1. EA cells were incubated with MTD
(61/40) for different time periods and cell lysates were prepared.
Figure 3. Externally applied mtDNA localizes to endosomes. HPAEC were reacted with mtDNA labeled with Alexa-488, FM4-64 (a marker for
endosomes) and NucBlue (a marker for nuclei). After 4 hr of incubation, cells were examined for dye localization by confocal microscopy. A. nuclei, B.
endosomes, and C. mtDNA were separately detected. Co-localization of mtDNA (Alexa 488) and the endosomal marker (FM4-64) is shown in D.
Experiments were repeated at least three times.
doi:10.1371/journal.pone.0059989.g003
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Blot. As shown in Figure 8C, expression of HMGB1 by
endothelial cells was immediately and strikingly increased by
incubation with MTD.
Discussion
Injury and shock syndromes can induce systemic inflammation
and subsequent organ dysfunction. We previously showed that
mitochondrial DNA circulates in the plasma at high concentra-
tions after trauma, shock and surgery [1,2,21]. Thus tissue
destruction leads to the circulation of mitochondrial damage
molecules, or DAMPs. We have shown that mitochondrial
DAMPs (MTD) are capable of activating inflammation and
PMN-mediated lung injury when injected systemically in vivo [1,2].
Moreover, the central role of mitochondrial formyl peptides in
PMN activation and function in vivo has since been corroborated
[22]. The possibility that endothelial cells might participate in the
systemic response to MTD released by tissue injury however, has
not been studied.
Systemic inflammatory response syndrome (SIRS) and related
organ failure syndromes (like ALI/ARDS) are often thought of as
reflecting the effects of inflammatory cytokine release on PMN-EC
interactions. But cytokine release is the delayed, indirect response
to injury seen after intermediate events transduce physical stimuli
into immune ‘Danger’ signals. Similarly, release of known
endothelial activators like thrombin is strictly limited to sites of
wounding. We hypothesized that MTD released from sites of
injury might participate in the acute activation PMN-EC
interactions that underlie the increased systemic endothelial
permeability typical of SIRS and ALI. In this context, we focused
Figure 4. Protease-treatment of MTD reduces permeability increase and calcium mobilization. (A) MT with or without sonication (MTD,
MT) were pretreated with protease. After heat inactivation of the protease, MT and MTD were applied to ECIS chambers as described before. Traces
represent mean and SD values from at least two wells. Experiments were repeated at least three times. (B) In addition to Figure 4 data, HBSS with
active protease was applied to EA cells. Active proteases instantly increase EC permeability. Experiments were repeated at least three times. 4C) and
4D): MTD with or without protease treatment (P-MTD, MTD) were applied to EA (4C) or HPAEC (4D) in the absence of extracellular calcium. Then
1.8 mM calcium was applied at the times indicated. The number of cells used for each measurement is shown in figures. Mean and SE values are
shown. Experiments were repeated at least three times.
doi:10.1371/journal.pone.0059989.g004
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activation and permeability in the presence and absence of PMN.
Although the concentrations of these molecules under clinical
conditions are difficult to ascertain, we have tried to maintain
translational relevance by examining the effects of biologic
mixtures of mitochondrial DAMPs removed directly from fresh
human cells and used at concentrations that produce similar
modest activations of PMN [Ca
2+]i flux. Moreover, we examine
the effects of mtDNA at concentrations known to be present in
plasma after injury [2]. Although this approach maintains clinical
relevance it has drawbacks. Unlike using commercial reagent
preparations, individual preparations of MTD or mtDNA is
moderately different. Thus application at concentrations with
similar bioactivity in one assay does not guarantee the same
responses in different assays (viz. Figures 1 and 2A, B, C). In fact,
MTD consists of a mixture of proteins, lipids and DNA and each
preparation likely has a slightly different ratio of these compo-
nents. Furthermore, it is still unknown which molecules or
molecular motifs MTD or mtDNA are responsible for the
regulation of endothelial permeability changes. Thus we used
mtDNA at concentrations that are observed in trauma patients
and whole sonicated mitochondria (MTD) at concentrations that
generate Ca
2+ flux responses associated with chemotaxis to
mitochondrial formyl peptides both in vitro and in in vivo in liver
injury models [2,22].
Using this ‘translational’ approach, we examined the effects of
mitochondrial DAMPs on permeability changes in endothelial
monolayers and then further evaluated key cell-cell interactions
and molecular pathways likely to be associated with the observed
endothelial responses. Our findings demonstrate that endothelial
cell monolayers (both EA and HPAEC) exposed to MTD show
a dose-dependent increase in permeability (Figure 1 A&B).
Under these conditions there were no additional changes in
permeability when PMN were added (Figure 1C). Thus when
present in sufficient quantity, MTD can elicit changes in
permeability directly, without the need for PMN. This may be
of clinical significance where patients are neutropenic or where
release of DAMPs is overwhelming. This increase in permeability
was associated with increased EC phosphorylation of MAPKs
(Figure 8 A&B) and [Ca
2+]i mobilization (Figures 4C&D, 7A).
These findings show that increased EC permeability after exposure
to MTD reflects the activation of cellular inflammatory pathways.
The kinetics of p38 and p44/42 activation were also markedly
different, suggesting as before [2] that MTD activates EC via
multiple signal pathways.
MTD dependent permeability increases were prevented by the
presence of proteases (Figure 4). Thus we show that proteins (and
specifically non-formylated proteins) in MTD must play a role in
MTD-induced EC permeability changes. Purified mtDNA also
affects EC permeability directly. But though mtDNA is present in
MTD in high concentration, protein degradation by proteases
diminishes MTD’s effect on permeability. This suggests that
mitochondrial proteins modify the effects of mtDNA through an
additional mechanism. We previously showed that MTD activates
PMN through mitochondrial formyl-peptides that act on FPR1
[5]. EC however, clearly do not respond to formyl peptides with
either a functional change in permeability (Figure 5A)o rb y
change in calcium signaling (Figure 5B). This is likely explained
by EC lacking FPR1. Interestingly, when MTD was applied to
EC, [Ca
2+]i increased in the absence of extracellular calcium
implicating release of endoplasmic Ca
2+ stores. Also, the addition
of calcium to the medium did not trigger calcium influx (Figure 4
C&D). Moreover, the morphology of the calcium increase was not
typical of a G-protein coupled receptor-induced store depletion.
Rather, the increases resembled a response to the membrane-
permeable diacylglycerol analog 1-oleoyl-2-acetyl-sn-glycerol
(OAG) [23]. Since protease treatments completely abolish calcium
mobilization it is unlikely that a mitochondrial lipid is involved.
Thus further investigation will be needed to delineate the
mechanisms by which MTD-induced Ca
2+ mobilization occurs
Figure 5. Formyl peptides have no effect on EC permeability or Ca
2+ mobilization. (A) 10 nM fMLP was applied to EA cells in ECIS
cultureware either separately or together with MTD or mtDNA. fMLP alone did not increase permeability and no additional increase was detected
when it was applied with MTD. The number of wells per condition is shown in parentheses: medium (1), fMLP (2), MTD (3), MTD+fMLP (3), mtDNA (3),
mtDNA+fMLP (3). Mean and SD values are shown. Each well contains 40 electrodes, thus each value comes from at least 40 individual values.
Experiments were repeated at least three times. (B) Various concentrations of fMLP were applied and failed to induce any calcium depletion from the
endoplasmic reticulum in EA cells. As a positive control, cells reacted readily to thrombin (1 U/mL), both releasing calcium from the ER and showing
calcium influx (SOCE) after addition of 1.8 mM extracellular calcium. Trace represents mean and SD values from at least 20 cells. Experiments were
repeated at least three times.
doi:10.1371/journal.pone.0059989.g005
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FPR-1 and 2-like receptors are likely not involved.
Unlike exposure to MTD (Figure 1A), exposure to purified
mtDNA caused only short-lived spikes in EC permeability
(Figure 2A). But when EC were exposed to mtDNA in the
presence of PMN, prolonged responses similar to those seen after
exposure to MTD were found (Figure 2A). Thus mtDNA can
increase EC permeability directly, or indirectly through PMN-EC
paracrine crosstalk. Externally applied mtDNA localized to
endosomes as confirmed by confocal microscopy (Figure 3) and
activated EC via mechanisms that were inhibitable by CQ (an
inhibitor of endosomal acidification) or ODNs that target
endosomal TLR receptors for CpG DNA (Figure 2 B&C). It is
still not clear which TLR(s) mtDNA binds to in EC endosomes,
although recent work shows that the effects of mtDNA on cardiac
muscle are at least partially due to its binding to TLR9 [24].
PMN adherence to EC commonly precedes increased perme-
ability and adding PMN to EC monolayers increased mtDNA-
induced permeability. We therefore examined whether mtDNA
increased PMN adherence to EC. mtDNA increased PMN
adherence to EC much like exposure to E.coli DNA or LPS
(Figure 6A). We examined the underlying mechanisms and found
that exposure to mtDNA and the associated increase in adherence
were associated with dramatically increased expression of the
Figure 6. mtDNA-treatment increases PMN adherence to endothelium by increasing adherence molecules on both EC and PMN. (A)
EA cells were treated by 10 or 20 mg/mL of mtDNA, E.coli DNA, or 10 ng/mL of LPS for 6 hrs. Calcein-loaded PMN were applied to EA cells for the last
1 hr of incubation and the percentage of PMN attached to the EA cells was determined as described in Methods. Data were normalized using
medium-treated cells as a control (100%). Mean and SE values from at least 6 experiments are shown. Compared to the medium control, mtDNA,
E.coli DNA, and LPS treatments all significantly increased PMN adherence to the EC. Experiments were repeated at least three times and studied by
One-way ANOVA. (B) EA cells were incubated with various concentrations of mtDNA (10 and 20 mg/mL), E.coli DNA (10 and 20 mg/mL), and 100 ng/
mL LPS for 6 hrs. 100 ng of cDNAs were prepared and loading was standardized. qPCR was then performed with specific primers for ICAM-1, E-
selectin, and GAPDH. Data were normalized by GAPDH and medium-treated cells as control (100%). Mean and SE values are shown from at least n=3.
6C) and 6D) PMN (3 million cells) were stimulated with mtDNA (20 mg/mL) for the indicated times. cDNAs were prepared and qPCR was performed
using CD11b, CD18, L-selectin and GAPDH primers. Data were normalized to GAPDH using medium-treated cells as the control (=100%). Mean and
SE values from n=6 are shown. (C): *: ,0.001, **:=0.036, (D): *:=0.022, **:=0.005, ***:,0.001, compared to time ‘‘0’’ value (analyzed by One Way
ANOVA, SigmaPlot 11).
doi:10.1371/journal.pone.0059989.g006
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counter-ligands CD18 and L-selectin in PMN (Figure 6 B, C,
and D). These findings support the concept that MTD
mobilization by direct cellular trauma can participate in patho-
logic PMN-EC interactions.
Elevations of cytosolic calcium ([Ca
2+]i) are a common mech-
anism of immune cell activation. We found mtDNA-treated PMN
to have an increased Ca
2+ influx response to TG (Figure 7A).
Increased Ca
2+ influx is a critical event in trauma and traumatic
ALI/ARDS [9,11,15]. Since PMN Ca
2+ influx depends on S1P
synthesis by Sphk1 [16], we next examined whether exposure to
mtDNA increased PMN Sphk1 expression. As shown in
Figure 7B, Sphk1 expression in PMN (at least at the mRNA
level) was increased by mtDNA, suggesting that mtDNA activates
PMN by increasing Sphk1 and S1P, thus leading to enhanced
store-operated calcium entry. S1P expressed intracellularly can act
as a ‘‘calcium influx factor’’ and increase calcium influx. We
believe such S1P synthesis may contribute to PMN activation and
subsequent increases in endothelial permeability, but further
investigations will be needed to test this hypothesis.
Such further investigations will involve direct evaluation of
intracellular S1P levels as we have shown previously [16] and
identification of the channels mediating SOCE and increased Ca
2+
influx after mtDNA exposure in this system. It is widely known
that extracellular S1P acts on the EC plasma membrane receptors
(S1PR1–5) to enhance barrier integrity [25,26]. But there is also
strong evidence that intracellular S1P synthesis activates store-
operated Ca
2+ channels. Increases in [Ca
2+]i due to SOCE in
PMN or EC could then activate pathways leading to increased
vascular permeability. Studies by our lab and others have
Figure 7. mtDNA increases SOCE and expression of Sphk1 in PMN. (A) Human PMN were treated with 20 mg/mL of E.coli DNA or mtDNA for
60 min then loaded with fura-2. Thapsigargin (1 mM) was applied to under nominally calcium-free conditions and then 1.8 mM extracellular calcium
was applied at the indicated times. Calcium influx was calculated as described elsewhere [9] as the area under the curve for [Ca
2+]i (AUC) over
120 sec. Data were analyzed using medium-treated PMN as 100%. Mean and SE values are shown. At least 3 experiment were done per condition. *
denotes a significant difference by student t-test (SigmaPlot 11) compared to time ‘‘0’’ value. Experiments were repeated at least three times. (7B)
Freshly isolated human PMN (5 million cells in 2 mL) were incubated with medium, mtDNA (10 mg/mL), E.coli DNA (10 mg/mL), or LPS (100 ng/mL) for
60 min. Then RNA and cDNA were prepared using the RNesay mini kit (Qiagen) and SuperScript VILO cDNA Synthesis kit (Life technologies),
respectively. 200 ng of cDNA per reaction was used for TaqMan qPCR assay for Sphk1 and GAPDH to evaluate expression levels. Sphk1 expression
levels were then further normalized by GAPDH using the medium control result as 100%. Four different PMN preparations were used for stimulation
and qPCR assays were done in triplicates. Mean and SE values from four different experiments are shown. Data were analyzed by One Way ANOVA. *
denotes a significant difference between mtDNA treatment and the medium control (p,0.05). No other significant differences were found.
doi:10.1371/journal.pone.0059989.g007
Figure 8. MTD activates MAPK and increases HMGB1 expression in EC. (A) EA cells were seeded on 6-well plates and incubated with MTD
(61/25) for the indicated times. Whole cell lysates were prepared and MAPK (p38) activation was evaluated by Western Blot analysis for
phosphorylated p38 (p-p38) and total p38. a-tubulin was used to evaluate loading accuracy. The data are representative of at least three experiments.
(B) Similar to 8A, activation of p44/42 MAPK was evaluated by Western Blot analyses for p44/42 and the p-p44/42 species. a-tubulin was used to
evaluate loading accuracy. Data are representative of at least three experiments. (C) Similar to 8 A and B, HMGB1 cellular expression was evaluated
after MTD stimulation. Data represent the results of at least three different experiments.
doi:10.1371/journal.pone.0059989.g008
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important non-receptor mediated role in the regulation of [Ca
2+]i
mobilization and cell permeability [11,16,27–29] after exposure to
GPCR ligands like thrombin, PAF or ATP, or to endoplasmic-
reticular Ca
2+ store depletion by other signaling agents [16]. Thus
we think understanding Sphk1 activation may be critical in
understanding endothelial permeability.
The increase in Sphk1 induced by mtDNA treatment
(Figure 7B) is therefore a novel and potentially important
finding. Our studies are still in progress, but the data suggest
mitochondrial DAMPs may activate Sphk1, S1P production and
regulate calcium influx that modulates endothelial permeability.
All of the formylated proteins in MTD are capable of activating
PMN [30] and many others may activate EC via SOCE
mechanisms. The protection of EC from increased permeability
by protease pre-treatment of the MTD shows that MT proteins
are indeed important. Moreover, diversity in EC Ca
2+ flux
responses may be an important source of the diversity in
endothelial responses seen in different vascular beds.
Finally, we show here for the first time that endothelial cell
expression of HMGB1 is up-regulated in inflammatory environ-
ments and that sterile mitochondrial motifs can activate HMGB1
expression. Although HMGB1 has been thought to act as a late
cytokine mediator of sepsis that activates cells via innate immune
receptors [20,31], we now know that HMGB1 can also be released
early after injury as a damage marker [18]. Here, rapid induction
of HMGB1 might create an autocrine or paracrine environment
conducive to increased adhesion and endothelial permeability.
Interestingly, the induction of HMGB1 in EC suggests a mecha-
nism by which EC could induce PMN inflammation as opposed to
PMN activating EC. Investigations of HMGB1 as a potential
‘short-arc’ inducer of local autocrine/paracrine inflammatory
responses are ongoing and will be the subject of later reports.
The ability of DAMPs derived from mitochondria to initiate
changes in endothelial permeability has not been previously
studied. The events described here are actually responses to
a spectrum of molecular species that can act on both EC and
PMN. The current work establishes that release of molecular
motifs from the mitochondria of disrupted, dead or dying cells may
be a critical event in determining early systemic endothelial
response to injury. Subsequent studies will be aimed at de-
termining the dominant active agonists and the pathways by which
they act.
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